Skip to main content
Clinical Trials/NCT01016652
NCT01016652
Completed
Not Applicable

Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

Johnson & Johnson Vision Care, Inc.0 sites49 target enrollmentOctober 1, 2009
ConditionsPresbyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Presbyopia
Sponsor
Johnson & Johnson Vision Care, Inc.
Enrollment
49
Primary Endpoint
Subject Reported Overall Vision Quality Using (CLUE)TM Questionnaire
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the effect of a multi-focal contact lens on symptomatic patients.

Registry
clinicaltrials.gov
Start Date
October 1, 2009
End Date
December 1, 2009
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • To have signed an informed consent form (documented by the investigator in the Case Report Form \[CRF\]).
  • Be existing daily wear spherical single-vision soft CL wearers (no extended wear in the last 3 months, but silicone hydrogels in daily wear are allowed).
  • Between 35 and 47 years of age (inclusive).
  • Have a CL spherical distance requirement between -1.00D and -6.00D (-6.50D refractive) in both eyes.
  • Refractive astigmatism of 0.75D or less in both eyes.
  • Visual symptoms associated with near vision
  • Be correctable to a visual acuity of 6/9 (20/30) or better in each eye.
  • Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having:
  • No amblyopia.
  • No evidence of lid abnormality or infection.

Exclusion Criteria

  • Monovision user or multifocal CL wearer.
  • Regular user of reading spectacles (i.e. daily usage).
  • Requires concurrent ocular medication.
  • Clinically significant (Grade 3 or 4) corneal stromal haze, corneal Vascularization, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate CL wear.
  • Corneal staining Grade 3 in more than two regions.
  • Has had any anterior ocular surgery. Has had any other ocular surgery or injury within 8 weeks immediately prior to enrollment for this study.
  • Pre-existing ocular irritation that would preclude CL fitting.
  • Keratoconus or other corneal irregularity.

Outcomes

Primary Outcomes

Subject Reported Overall Vision Quality Using (CLUE)TM Questionnaire

Time Frame: week 4

The Contact Lens User Experience (CLUE) Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response, with scores ranging from 0-120.

Monocular Amplitude of Accommodation

Time Frame: week 4

The amplitude of accommodation is a measure of the eyes ability to accommodate or focus on near objects. The method used was the push-up/push-down method performed monocularly. One eye was occluded and using the smallest print the subject was able to read, the reading chart was slowly moved towards the subject. The subject was asked them to indicate when the print first becomes blurred. The distance was noted and the amplitude of accommodation was calculated.

Secondary Outcomes

  • Comfortable Wearing Time(week 4)
  • Proportion of Subjects With Near Vision Symptoms as Assessed by the NVQ(week 4)
  • Subject Reported Lens Comfort Using CLUE Questionnaire(week 4)
  • Proportion of Subjects Benefiting From the Binocular +/-1.00D Accommodative Flipper(Baseline)

Similar Trials